ES8707182A1 - N,3-disubstituted 2-oxyindole-1-carboxamide as analgesic andantiinflammatory - Google Patents

N,3-disubstituted 2-oxyindole-1-carboxamide as analgesic andantiinflammatory

Info

Publication number
ES8707182A1
ES8707182A1 ES551275A ES551275A ES8707182A1 ES 8707182 A1 ES8707182 A1 ES 8707182A1 ES 551275 A ES551275 A ES 551275A ES 551275 A ES551275 A ES 551275A ES 8707182 A1 ES8707182 A1 ES 8707182A1
Authority
ES
Spain
Prior art keywords
analgesic
carboxamide
compound
formula
andantiinflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551275A
Other languages
Spanish (es)
Other versions
ES551275A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES551275A0 publication Critical patent/ES551275A0/en
Publication of ES8707182A1 publication Critical patent/ES8707182A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDURE FOR THE PREPARATION OF A COMPOUND OF 2-OXINDOL-1-CARBOXAMIDE. IT CONSISTS OF REACTIONING A COMPOUND OF FORMULA (II) WITH A CARBOXYLIC ACTIVE DERIVATIVE OF FORMULA R1-C (F) -OH, IN AN INERT SOLVENT AND AT A TEMPERATURE BETWEEN C10 AND 25ºC, TO OBTAIN A COMPOUND OF 2-OXINDOL-1-CARBOXIDE FROM FORMULA (I) WHERE X IS H, FLUORINE, CHLORINE, BROMINE, CYCLOALKYL FROM C 3 TO 7 AND OTHERS; Y IS H, FLUORINE, CHLORINE, BROMINE, ALKYL FROM C 1 TO 4 AND OTHERS; R1 IS ALKYL FROM C 1 TO 6, CYCLLOALKYL WITH C 4 TO 7, PHENYL AND OTHERS; AND R2 IS RENT OF C 1 TO 6, FURILO, BENCILO AND OTHERS. IT HAS PHARMACEUTICAL APPLICATIONS AS AN ANALGESIC IN POSTOPERATIVE STATES AND IN RHEUMATIC DISEASES. (Machine-translation by Google Translate, not legally binding)
ES551275A 1984-05-04 1986-01-27 N,3-disubstituted 2-oxyindole-1-carboxamide as analgesic andantiinflammatory Expired ES8707182A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
ES551275A0 ES551275A0 (en) 1987-07-16
ES8707182A1 true ES8707182A1 (en) 1987-07-16

Family

ID=24431933

Family Applications (2)

Application Number Title Priority Date Filing Date
ES542813A Expired ES8609248A1 (en) 1984-05-04 1985-05-03 N,3-disubstituted 2-oxyindole-1-carboxamide as analgesic andantiinflammatory
ES551275A Expired ES8707182A1 (en) 1984-05-04 1986-01-27 N,3-disubstituted 2-oxyindole-1-carboxamide as analgesic andantiinflammatory

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES542813A Expired ES8609248A1 (en) 1984-05-04 1985-05-03 N,3-disubstituted 2-oxyindole-1-carboxamide as analgesic andantiinflammatory

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
MA20424A1 (en) 1985-12-31
PL145416B1 (en) 1988-09-30
ZW7885A1 (en) 1985-07-24
OA08098A (en) 1987-03-31
KR850008154A (en) 1985-12-13
RU2017729C1 (en) 1994-08-15
NO163132C (en) 1990-04-11
PL257892A1 (en) 1986-10-07
RO94455B (en) 1988-07-01
AR241159A2 (en) 1991-12-30
FI80016C (en) 1990-04-10
IE851103L (en) 1985-11-04
RO94455A (en) 1988-06-30
ES551275A0 (en) 1987-07-16
IN161509B (en) 1987-12-19
BG60208B2 (en) 1993-12-30
FI851756L (en) 1985-11-05
DD232916A5 (en) 1986-02-12
CS320285A2 (en) 1987-03-12
YU44998B (en) 1991-06-30
RO91141A (en) 1987-06-30
AR241159A1 (en) 1991-12-30
ES8609248A1 (en) 1986-07-16
HU196057B (en) 1988-09-28
ES542813A0 (en) 1986-07-16
BG60207B2 (en) 1993-12-30
RO91141B (en) 1987-07-03
ZA853324B (en) 1986-12-30
JPS60243068A (en) 1985-12-03
MW1685A1 (en) 1986-09-10
YU73085A (en) 1988-04-30
NO851774L (en) 1985-11-05
CS252828B2 (en) 1987-10-15
KR870000497B1 (en) 1987-03-12
PL253203A1 (en) 1986-06-17
PT80375B (en) 1987-09-30
SU1468413A3 (en) 1989-03-23
EG17193A (en) 1990-08-30
PT80375A (en) 1985-05-01
HUT37754A (en) 1986-02-28
MX5839A (en) 1993-11-01
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
FI851756A0 (en) 1985-05-03
NO163132B (en) 1990-01-02
FI80016B (en) 1989-12-29

Similar Documents

Publication Publication Date Title
ES479369A1 (en) Spiro-(dihydrobenzofuranpiperidines and -pyrrolidines) and derivatives thereof, methods for their preparation and medicines containing them.
GB1490306A (en) 3-amino-indazolecarboxylic acid derivatives process for their preparation and their use as medicaments
NO931482L (en) PHARMACEUTICAL COMPOSITIONS CONTAINING QUINOLINE AND QUINAZOLINE DERIVATIVES AND NEW COMPOUNDS FOR THESE
KR900014388A (en) Carbonate Derivatives of Eserolin, Methods for Making the Same, and Uses as Pharmaceuticals
ES8707182A1 (en) N,3-disubstituted 2-oxyindole-1-carboxamide as analgesic andantiinflammatory
ES446993A1 (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
ES318983A1 (en) A procedure for the preparation of quinolein derivatives. (Machine-translation by Google Translate, not legally binding)
PT76812B (en) Process for the preparation of a fungicidal composition containing substituted maleic imides
SE8107524L (en) Heterocyclic Associations
EP0074130A3 (en) New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
DE3780577D1 (en) ANTI-INFLAMMATORY COMPOSITIONS.
NO159854C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BETA-CARBOLIN-3-CARBOXYLIC ACID DERIVATIVES.
JPS52151144A (en) Preparation of 2-substituted-acrylic amide and 2-substituted-propionic acid derivatives
GB1174673A (en) Substituted Phenyl Acetamides, a Process for their Manufacture and Preparations Containing Them
GB1448547A (en) Derivative of phenylacetic acid
SE8402361L (en) NEW ACYLAMINOPHENOLD DERIVATIVES
ES8505178A1 (en) Compound with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom.
ES8606273A1 (en) A procedure for the preparation of 2- oxindol compounds (Machine-translation by Google Translate, not legally binding)
SE8107470L (en) imidazole
NO933237L (en) Absorbate of an excipient mixture and a non-solid active substance for the manufacture of pharmaceutical preparations
GB1262333A (en) New hydantoins their preparation and compositions containing them
ATE7695T1 (en) 1-AROYL-2-PHENYLAMINO-2-IMIDAZOLINE, ITS PREPARATION AND PHARMACEUTICALS CONTAINING THEM.
JPS5427532A (en) Preparation of optical active 2-(substituted phenyl)-3-methyl-butyric acid chloride
DE3061396D1 (en) Oxazoline and thiazoline derivatives, processes for their preparation and pharmaceutical compositions containing them
JPS6438067A (en) 1,4-dihydropyridine derivative labeled with deuterium

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060128